PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

LinkedIn

IV Thrombolysis Before Thrombectomy Improves Recanalization in Extended Window

alteplaseintravenous thrombolysismechanical thrombectomylarge vessel occlusionacute ischemic strokeextended time windowperfusion imagingtarget trial emulationtenecteplaseneuropharmacology Neurology / Neuropharmacology

Background Information

IVT pre-MT improves stroke recanalization success post-4.5 hours.

Determining whether direct mechanical thrombectomy (MT) is non-inferior to combined intravenous thrombolysis (IVT) and MT in an extended time window is crucial for optimizing acute stroke treatment. Direct MT did not demonstrate non-inferiority to IVT + MT beyond 4.5 hours, with lower successful recanalization rates in the direct MT group (adjOR 0.38). Findings suggest that IVT prior to MT might improve recanalization success in extended windows. Limitations include potential biases inherent to emulated trial designs. IVT before MT enhances recanalization success in the extended treatment window.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report.
Subscribe for Full Access →

Authors: Nicolini E, Ciacciarelli A, Pracucci G, Saia V, Simonetti L, Zini A, Da Ros V, D'agostino F, Iacobucci M, De Michele M, Andrighetti M, Tassi R, Saletti A, Casetta I, Fainardi E, Pauciulo A, Caggiula M, Menozzi R, Pezzini A, Vallone S, Bigliardi G, Zimatore DS, Petruzzellis M, Comai A, Franchini E, Allegretti L, Tassinari T, Limbucci N, Nencini P, Carità G, Russo M, Filizzolo M, Mannino M, Ruggiero M, Longoni M, Boghi A, Naldi A, Bergui M, Bosco G, Pelle G, Alessiani M, Alberti M, Invernizzi P, Augelli R, Cappellari M, Lazzarotti GA, Giannini N, Konda D, Sallustio F, Mangiafico S, Toni D, IRETAS group

Citation: Nicolini E, Ciacciarelli A, Pracucci G, et al. Direct Thrombectomy vs. Combined Treatment With Intravenous Thrombolysis in the Extended Time Window: A Target Trial Emulation. European journal of neurology. 2026;33(7):e70682. doi:10.1111/ene.70682

Article Links: PubMed · Journal / DOI

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Want the full analysis?

Subscribe to PharmD Signal for unrestricted access to every deep analysis, plus PDF reports, GRADE evidence grades, and pharmacist implications for every article we publish.

Become a Subscriber →